Race Oncology

0 followers

‌

Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.

Industries

Headquarters

Employees

Links

Org chart

Managing Director And Chief Executive Officer

Daniel Tillett

Collapse

Chair

1 members

Takeda Pharmaceutical

101 followers

Catalent

13 followers

Cipla

7 followers

Alkem Laboratories Ltd

8 followers

Hikma Pharmaceuticals

5 followers

AbbVie

149 followers

Aspen Pharmacare

3 followers

Incyte

14 followers

Rocket Pharmaceuticals

2 followers

ISDIN

2 followers

Commonwealth Bank of Australia

88 followers

Discover companies